DIA

Icon, DIA to deliver new educational product

Monday, February 11, 2013 09:53 AM

Icon,a global provider of outsourced development, has formed a collaboration with DIA, a neutral, global, professional, member-driven association of nearly 18,000 pharmaceutical, biotechnology, and medical device professionals, to deliver the first solution-provider webinar, which offers free access to knowledge and innovative solutions to overcome some of the key challenges in medical product development.

More... »

Ampio forms Luoxis Diagnostics to commercialize ORP tech

Monday, February 11, 2013 09:25 AM

Luoxis Diagnostics, a newly incorporated subsidiary of Ampio Pharmaceuticals, a biopharmaceutical company focused on prevalent inflammatory diseases, has initiated its operations that will initially be funded through a private placement, with Ampio maintaining approximately 80% ownership post financing.

More... »

Novo Nordisk promotes four to senior vice president

Friday, February 1, 2013 02:39 PM

Novo Nordisk, a global healthcare company, has promoted four corporate vice presidents to senior vice presidents. Effective March 1, 2013, the following members of the U.S. executive team will assume the title of senior vice president in their respective areas: Andy Ajello, U.S. national diabetes sales; Camille Lee, U.S. diabetes marketing; Alan Moses, MD, global chief medical officer; and Anne Phillips, MD, U.S. clinical, medical and regulatory affairs.

More... »

DIA names Stephen P. Spielberg editor-in-chief of TIRS journal

Friday, January 25, 2013 11:59 AM

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, announced the arrival of Stephen P. Spielberg, M.D., Ph.D., as editor-in-chief of the newly launched, official DIA peer-reviewed scientific journal, Therapeutic Innovation & Regulatory Science (TIRS).

More... »

Verum.de to provide clinical research services for oncology center in Romania

Wednesday, January 23, 2013 02:38 PM

Verum.de, a Germany-based full-clinical service CRO, has entered into an agreement with the Center for Oncologic Diagnosis and Treatment (Oncocard) in Romania to be its preferred provider of clinical trial services.

More... »

DIA appoints Lyngvig as new European director

Tuesday, December 18, 2012 01:55 PM

DIA, a neutral, global, professional and member-driven association of nearly 18,000 professionals, has appointed Jytte Lyngvig as director for DIA Europe.

More... »

DIA begins transition to new executive leadership

Monday, December 10, 2012 09:12 AM

DIA, a neutral, global, nonprofit association that provides knowledge resources across the full spectrum of medical product development, announced that Paul Pomerantz, worldwide executive director of DIA, will be leaving effective March 3, 2013, to assume the position of CEO for the American Society of Anesthesiologists.

More... »

Saladax Biomedical appoints Myslinski as CCO

Friday, November 16, 2012 12:18 PM

Saladax Biomedical, a Bethlehem, Penn.-based privately held company that develops diagnostic assays for the practical delivery of personalized medicine, has appointed Mark D. Myslinski as senior vice president and chief commercial officer.

More... »

CRA, Radiant Research form largest, most therapeutically diverse SMO in U.S.

Monday, November 5, 2012 01:15 PM

CRA Holdings has acquired Radiant Research, a comprehensive research company based in Cincinnati. Clinical Research Advantage (CRA), a provider of research services also owned by CRA Holdings, will be combined with Radiant Research, creating an organization with 57 sites with more than 550 research professionals and an aggressive plan for growth.

More... »

CRA Holdings acquires Radiant Research

Friday, October 26, 2012 03:16 PM

Kinderhook Industries has announced the acquisition of Radiant Research by CRA Holdings, one of its portfolio companies. The deal represents the eighth healthcare services transaction completed by Kinderhook. Financial terms of the transaction were not disclosed.

More... »